Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer

被引：0
|
作者：
E Mochiki
K Ogata
T Ohno
Y Toyomasu
N Haga
Y Fukai
R Aihara
H Ando
N Uchida
T Asao
H Kuwano
机构：
[1] Graduate School of Medicine,Department of General Surgical Science
[2] Gunma University,Department of Surgery
[3] Gunma Prefecture Saiseikai-Maebashi Hospital,Department of Surgery
[4] Saitama Medical Center,Department of Surgery
[5] Gunma Cancer Center Hospital,Department of Surgery
[6] Fujioka General Hospital,Department of Surgery
[7] Haramachi Red Cross Hospital,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
gastric cancer; chemotherapy; S-1; paclitaxel; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：31 / 36
页数：5
相关论文
共 50 条
  • [31] A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
    Naoki Uemura
    Shohei Kikuchi
    Yasushi Sato
    Hiroyuki Ohnuma
    Koichi Okamoto
    Hiroshi Miyamoto
    Masahiro Hirakawa
    Tamotsu Sagawa
    Koshi Fujikawa
    Yasuo Takahashi
    Toshinori Okuda
    Shinya Minami
    Minoru Takahashi
    Tetsuro Okamoto
    Kohichi Takada
    Koji Miyanisi
    Tetsuji Takayama
    Junji Kato
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 707 - 713
  • [32] Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma
    Harada, Koji
    Sato, Mitsunobu
    Ueyama, Yoshiya
    Nagayama, Masaru
    Hamakawa, Hiroyuki
    Nagahata, Shunichirou
    Yoshimura, Yasuro
    Osaki, Tokio
    Ryoke, Kazuo
    ANTI-CANCER DRUGS, 2008, 19 (01) : 85 - 90
  • [33] A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer
    Nakayama, Norisuke
    Ishido, Kenji
    Chin, Keisho
    Nishimura, Ken
    Azuma, Mizutomo
    Matsusaka, Satoshi
    Inokuchi, Yasuhiro
    Tanabe, Satoshi
    Kumekawa, Yosuke
    Koizumi, Wasaburo
    GASTRIC CANCER, 2017, 20 (02) : 350 - 357
  • [34] Phase III study comparing intraperitoneal paclitaxel plus S-1/paclitaxel with S-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Fujiwara, Y.
    Ishigami, H.
    Fukushima, R.
    Nashimoto, A.
    Yabusaki, H.
    Imamoto, H.
    Imano, M.
    Kodera, Y.
    Uenosono, Y.
    Amagai, K.
    Kadowaki, S.
    Miwa, H.
    Yamaguchi, H.
    Yamaguchi, T.
    Kitayama, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer
    Norisuke Nakayama
    Kenji Ishido
    Keisho Chin
    Ken Nishimura
    Mizutomo Azuma
    Satoshi Matsusaka
    Yasuhiro Inokuchi
    Satoshi Tanabe
    Yosuke Kumekawa
    Wasaburo Koizumi
    Gastric Cancer, 2017, 20 : 350 - 357
  • [36] Randomized phase III study of S-1 alone versus S-1+cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer
    Narahara, H.
    Koizumi, W.
    Hara, T.
    Takagane, A.
    Akiya, T.
    Takagi, M.
    Miyashita, K.
    Nishizaki, T.
    Kobayashi, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer
    Tomimoto, Hideki
    Hanibuchi, Masaki
    Ogushi, Fumitaka
    Okano, Yoshio
    Shinohara, Tsutomu
    Doi, Hiroyuki
    Yamamoto, Akiyoshi
    Takeuchi, Eiji
    Yamamoto, Akihiko
    Azuma, Masahiko
    Tada, Hiroya
    Kanematsu, Takanori
    Kakiuchi, Soji
    Goto, Hisatsugu
    Yano, Seiji
    Nishioka, Yasuhiko
    Sone, Saburo
    ONCOLOGY LETTERS, 2011, 2 (03) : 465 - 470
  • [38] Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
    Lee, KW
    Im, SA
    Yun, T
    Song, EK
    Na, II
    Shin, H
    Choi, IS
    Oh, DY
    Kim, JH
    Kim, DW
    Kim, TY
    Lee, JS
    Heo, DS
    Bang, YJ
    Kim, NK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (12) : 720 - 726
  • [39] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Dae Young Zang
    Dae Hyun Yang
    Hae Wan Lee
    Se Won Hwang
    Hun Ho Song
    Joo Young Jung
    Jung Hye Kwon
    Hyo Jung Kim
    Jung Han Kim
    Sa Rah Park
    Min-Jeong Kim
    Kyung Mi Jang
    Choong Kee Park
    Jong Hyeok Kim
    Bong Hwa Lee
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 509 - 516
  • [40] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Zang, Dae Young
    Yang, Dae Hyun
    Lee, Hae Wan
    Hwang, Se Won
    Song, Hun Ho
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Hyo Jung
    Kim, Jung Han
    Park, Sa Rah
    Kim, Min-Jeong
    Jang, Kyung Mi
    Park, Choong Kee
    Kim, Jong Hyeok
    Lee, Bong Hwa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 509 - 516
12345